Ziccum enters into evaluation agreement with global pharmaceutical and vaccine company

Booking.com

Stockholm, October 3, 2019. Ziccum AB (publ) (‘Ziccum’) is to conduct an evaluation study with a global healthcare company engaged in researching and developing, vaccines and proteins to combat infectious diseases. The project will explore whether Ziccum’s air-drying capabilities could generate stable, dry-form vaccines for the company. 1-in-5 children worldwide currently do not receive even basic vaccines (WHO), and 1.5 million die every year from vaccine-preventable diseases.
“We’re very proud to be starting this pilot project for such a prestigious and committed pharma company”, says

Source: Ziccum enters into evaluation agreement with global pharmaceutical and vaccine company

Booking.com
Booking.com

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.